A Quantitative Assessment of Discordance Rates Between Preoperative MRI Restaging and Postoperative Pathologic Reports in Patients Undergoing Rectal Resection Following Neoadjuvant Therapy – A Word of Caution Regarding Patient-Selection for watch-and-wait Strategies

Clicks: 1
ID: 315749
2026
Free PDF
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This article has not been analysed, so there is no overall score — reader engagement is measured and shown alongside.
AI Quality Assessment
Not analyzed
Readership in this journal

Ranked #387 of 432 articles by views in the british journal of surgery

Most read Least read

Bar heights use a square-root scale. Only the 120 most-read articles are drawn; the journal has 432 in total.

Mint this article as an NFT
Not yet minted

Create a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.

5 SUSD one-off · no wallet required
Sign in to mint
Abstract
Abstract Background Accurate restaging after neoadjuvant therapy (NAT) is crucial in the management of rectal cancer, especially in centers that aim to implement organ-preserving watch-and-wait (W&W) strategies for patients achieving complete remission (CR). MRI is the cornerstone of restaging, but its diagnostic accuracy remains debated, with both overstaging and understaging reported. Such discrepancies can lead to unnecessary resections in true complete responders or to potentially detrimental undertreatment in patients with residual disease. Aims This study evaluated the concordance between MRI-based restaging and pathological staging in patients who underwent TME following NAT at our institution. Methods Retrospective analysis of patients with rectal cancer who underwent NAT (chemotherapy, radiotherapy, chemoradiotherapy or immunotherapy) followed by surgical resection between 2018 and 2024 at our institution. Results A total of 113 patients were eligible for analysis. In 51 patients preoperative MRI-based tumor regression grade (ymrTRG) and pathological tumor regression grade (ypTRG) (Dworak) was available. Overall, 31.4% were staged correctly, while 33.3% were overstaged radiologically and 35.3% radiologically understaged. In 38 patients, preoperative ymrT and ypT staging was available. Correct preoperative radiological staging was achieved in 36.8%, while 47.4% were radiologically overstaged and 15.8% radiologically understaged. ymrT0 was reported in 2 patients of which one resulted in ypT0 and the other in ypT1. ypT0 was reported in 6 patients of which only 1 patient had a preoperative ymrT0 staging. Two patients were staged ymrT2, 2 patients ymrT3 and one patient ymrT4. Conclusion MRI restaging after neoadjuvant therapy showed limited accuracy in identifying CR. Both overstaging and understaging were frequent, resulting in clinically relevant consequences. In clinical practice, these findings emphasize the need for a cautious and multimodal approach to restaging. MRI results should always be interpreted in conjunction with endoscopy and digital rectal examination. For centers offering organ-preserving strategies, knowledge of the limited reliability of restaging MRI to detect full remission is crucial for w&w patient selection and early recognition of tumor regrowth.Figure 1.Diagram showing preoperative mrT compared to postoperative pT staging (yellow: radiological understaging, blue: radiological overstaging, green: correct staging)For image description, please refer to the figure legend and surrounding text.
Reference Key
openalex_W7163399576 Use this key to autocite in the manuscript while using SciMatic Manuscript Manager or Thesis Manager
Authors S Dindo, M Ramser, S Hügli, R Fritsch, M Turina
Journal the british journal of surgery
Year 2026
DOI
10.1093/bjs/znag055.042
URL
https://doi.org/10.1093/bjs/znag055.042
Keywords Keywords not found

Citations

No citations found. To add a citation, contact the admin at info@scimatic.org

Comments

No comments yet. Be the first to comment on this article.